These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33245786)

  • 1. Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan.
    Asano K; Aoi Y; Kamada S; Uyama Y; Tohkin M
    Clin Pharmacol Ther; 2021 Jun; 109(6):1555-1563. PubMed ID: 33245786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical Trials.
    Ushijima S; Matsumaru N; Tsukamoto K
    Pharmaceut Med; 2021 Jul; 35(4):253-260. PubMed ID: 34291425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and Japan.
    Aoi Y; Kato Y; Asano K; Otsubo Y; Uyama Y
    Ther Innov Regul Sci; 2023 Nov; 57(6):1298-1303. PubMed ID: 37587270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICH E9 guideline 'Statistical principles for clinical trials': a case study.
    Phillips A; Haudiquet V
    Stat Med; 2003 Jan; 22(1):1-11; discussion 13-7. PubMed ID: 12486747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
    O'Neill RT
    Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspective.
    Ando Y; Hamasaki T
    Pharm Stat; 2010; 9(3):190-200. PubMed ID: 20737442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of estimand framework to the design and analysis of multi-regional clinical trials.
    Niu C; Liang L; Fu R; Zhong W; Wang WWB
    J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38840476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(97):29665-6. PubMed ID: 22616137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiregional clinical trials: Japanese perspective on drug development strategy and sample size for Japanese subjects.
    Ando Y; Uyama Y
    J Biopharm Stat; 2012 Sep; 22(5):977-87. PubMed ID: 22946944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Consistency of Treatment Response Across Regions-the LEADER Trial in Relation to the ICH E17 Guideline.
    Nielsen HK; DeChiaro S; Goldman B
    Front Med (Lausanne); 2021; 8():662775. PubMed ID: 34136501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reshaping the carcinogenic risk assessment of medicines: international harmonisation for drug safety, industry/regulator efficiency or both?
    Abraham J; Reed T
    Soc Sci Med; 2003 Jul; 57(2):195-204. PubMed ID: 12765701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Differences During the ICH Regulatory Consultation Process Between the EU, US, and Japan.
    Torqui A; Macau AM
    Ther Innov Regul Sci; 2018 Jul; 52(4):438-441. PubMed ID: 29714552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy Comparison for a Schizophrenia and a Dysuria Drug Among East Asian Populations: A Retrospective Analysis Using Multi-regional Clinical Trial Data.
    Sai K; Nakatani E; Iwama Y; Hiraoka S; Tohkin M; Uyama Y; Saito Y
    Ther Innov Regul Sci; 2021 May; 55(3):523-538. PubMed ID: 33393013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian multiregional clinical trials using model averaging.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2023 Apr; 24(2):262-276. PubMed ID: 34296263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of global versus Asian clinical trial strategies supportive of registration of drugs in Japan.
    Shirotani M; Kurokawa T; Chiba K
    J Clin Pharmacol; 2014 Jul; 54(7):753-64. PubMed ID: 24496890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Investigators' Brochure: a comparison of the draft international conference on harmonisation guideline with current Food and Drug Administration requirements.
    Cocchetto DM
    Qual Assur; 1995 Dec; 4(4):240-6. PubMed ID: 8890349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Conference on Harmonisation; S10 Photosafety Evaluation of Pharmaceuticals; guidance for industry; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Jan; 80(17):4282-3. PubMed ID: 25730921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The necessary conduct: Exploratory multiregional clinical trials in East Asia.
    Jeon I; Kim YK; Song I; Yoon DY; Huh KY; Jin X; Yu KS; Lee S; Kumagai Y; Jang IJ
    Clin Transl Sci; 2021 Nov; 14(6):2399-2407. PubMed ID: 34397152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.